C-The Missing Tenet Within the ABCDEF Bundle.
C-The Missing Tenet Within the ABCDEF Bundle.
复制标题
C-ABCDEF 捆绑包中缺失的原则。
DOI：
10.1097/ccm.0000000000004311
复制
发表时间：
2020
影响因子：
8.8
通讯作者：
Happ,MaryBeth
中科院分区：
文献类型：
--
作者：
Patak,Lance;Tate,JudithA;Happ,MaryBeth
Patak博士目前是Vidatak，LLC的成员和股东。Vidatak是美国国立卫生研究院（NIH）小企业技术转让（STTR）资助NR 014087的公司接受者，该资助与俄亥俄州州立大学合作指导了VidaTalk的开发，并且是EZ Board和VidaTalk的制造商。Happ博士与Vidatak，LLC合作，作为NIH STTR Grant NR 014087的主要研究者（PI），反复开发和测试VidaTalk患者沟通应用程序，Happ博士拥有辅助沟通策略2（SPEACS-2）沟通培训计划的患者-护士有效性研究的版权。Happ博士所在的机构获得了NIH/国家护理研究所（NINR）R42-NR 014087、NIH/国家老龄化研究所R 01 AG 045176 -05、NIH/NINR R 01-NR 017018 -02-S（MK Song，PI; Happ博士，共同研究者）的资助，她还获得了纽约大学Langone医学中心（酬金）的资助。Happ博士透露，SPEACS-2沟通培训计划的个人继续教育报名由俄亥俄州州立大学护理学院继续教育平台接收; Happ博士没有收到任何收益。Tate博士透露，她没有任何潜在的利益冲突。
Dr. Patak currently serves as a member and is a shareholder of Vidatak, LLC. Vidatak was the company recipient for National Institutes of Health (NIH) Small Business Technology Transfer (STTR) Grant NR014087 which guided the development of VidaTalk in concert with The Ohio State University and is the manufacturer of the EZ Board and VidaTalk. Dr. Happ collaborated with Vidatak, LLC, as principal investigator (PI) for NIH STTR Grant NR014087 to iteratively develop and test the VidaTalk patient communication application, and Dr. Happ holds copyright to the Study of Patient-Nurse Effectiveness with Assisted Communication Strategies-2 (SPEACS-2) communication training program. Dr. Happ’s institution received funding from NIH/National Institute of Nursing Research (NINR) R42-NR014087, NIH/National Institute on Aging R01AG045176-05, NIH/NINR R01-NR017018-02-S (MK Song, PI; Dr. Happ, co-investigator), and she received funding from New York University Langone Medical Center (honorarium). Dr. Happ disclosed that Individual Continuing education enrollments to the SPEACS-2 communication training program are received by the Ohio State University College of Nursing continuing education platform; Dr. Happ has not received any proceeds. Dr. Tate has disclosed that she does not have any potential conflicts of interest.